Moisand Fitzgerald Tamayo’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-50
Closed -$140 581
2025
Q2
$140 Hold
50
﹤0.01% 572
2025
Q1
$180 Hold
50
﹤0.01% 575
2024
Q4
$158 Hold
50
﹤0.01% 589
2024
Q3
$141 Hold
50
﹤0.01% 605
2024
Q2
$62 Hold
50
﹤0.01% 583
2024
Q1
$40 Hold
50
﹤0.01% 571
2023
Q4
$48 Hold
50
﹤0.01% 643
2023
Q3
$54 Hold
50
﹤0.01% 752
2023
Q2
$45 Hold
50
﹤0.01% 744
2023
Q1
$43 Hold
50
﹤0.01% 774
2022
Q4
$46 Hold
50
﹤0.01% 763
2022
Q3
$0 Hold
50
﹤0.01% 729
2022
Q2
$0 Hold
50
﹤0.01% 604
2022
Q1
$0 Hold
50
﹤0.01% 526
2021
Q4
$0 Hold
50
﹤0.01% 386
2021
Q3
$0 Hold
50
﹤0.01% 376
2021
Q2
$1K Hold
50
﹤0.01% 382
2021
Q1
$0 Buy
+50
New +$564 ﹤0.01% 362

Other funds holding CLOV

Moisand Fitzgerald Tamayo's CLOV Position: Q3 2025 in Review

Moisand Fitzgerald Tamayo sold out of Clover Health Investments (CLOV) in Q3 2025, closing a stake of 50 shares — an estimated $140 sold.

Moisand Fitzgerald Tamayo first reported a position in CLOV in Q1 2021 and held it in 18 quarters. The position peaked at $1K in Q2 2021. 201 funds tracked by Wall St. Rank hold CLOV as of Q3 2025.

  • Moisand Fitzgerald Tamayo reported no remaining Clover Health Investments position as of Q3 2025 after selling out during the quarter.
  • Moisand Fitzgerald Tamayo sold 50 Clover Health Investments shares in Q3 2025, an estimated $140.
  • Moisand Fitzgerald Tamayo first reported a position in Clover Health Investments in Q1 2021 and held it in 18 quarters.
  • Moisand Fitzgerald Tamayo's Clover Health Investments position peaked at $1K in Q2 2021.
  • 201 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2025.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q3 2025, filed 23 Oct 2025.